These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12494073)

  • 1. [The use of combination therapy with lacidipine and beta-adrenoblockers in patients with hypertension].
    Glezer MG; Abil'dinova AZh
    Kardiologiia; 2002; 42(9):43-8. PubMed ID: 12494073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihypertensive agents used as first line agents: beta-blockers under pressure].
    Burnier M; Pechère A; Waeber B
    Rev Med Suisse; 2006 Sep; 2(78):2019-20. PubMed ID: 17019836
    [No Abstract]   [Full Text] [Related]  

  • 3. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of lacidipine and atenolol in mild to moderate hypertension.
    Lyons D; Fowler G; Webster J; Hall ST; Petrie JC
    Br J Clin Pharmacol; 1994 Jan; 37(1):45-51. PubMed ID: 8148217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta blockers in hypertension treatment Will stepping back come soon?].
    Sawicki PT; Anlauf M; Haller H
    MMW Fortschr Med; 2007 Mar; 149(11):6. PubMed ID: 20104695
    [No Abstract]   [Full Text] [Related]  

  • 7. Atenolol and cardiovascular risk: an issue close to the heart.
    Wilkinson IB; McEniery CM; Cockcroft JR
    Lancet; 2006 Feb; 367(9511):627-9. PubMed ID: 16503444
    [No Abstract]   [Full Text] [Related]  

  • 8. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S; Kendall M
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
    Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

  • 13. Metoprolol succinate combination in the treatment of hypertension.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].
    Lazebnik LB; Mikheeva OM; Toporkov AS; Komissarenko IA; Vasnev OS; Fedulenkova LV
    Eksp Klin Gastroenterol; 2007; (5):57-66. PubMed ID: 18389599
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of atenolol vs metoprolol succinate on vascular function in patients with hypertension.
    Heffernan KS; Suryadevara R; Patvardhan EA; Mooney P; Karas RH; Kuvin JT
    Clin Cardiol; 2011 Jan; 34(1):39-44. PubMed ID: 21259277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of antihypertensive agents from various pharmacological groups on blood pressure reaction during stress-testing. Part I. Comparative characteristics of medications, exerting effect of sympathoadrenal block].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA; Savel'eva SA
    Kardiologiia; 2008; 48(3):44-51. PubMed ID: 18429756
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
    Mancia G; Parati G; Bilo G; Maronati A; Omboni S; Baurecht H; Hennig M; Zanchetti A
    J Hypertens; 2007 May; 25(5):1087-94. PubMed ID: 17414674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.